Effect of tumour necrosis factor-α on proliferation, activation and protein synthesis of rat hepatic stellate cells

Journal of Hepatology

Volumn 27, Issue 6, 1997, Pages 1067-1080

  Knittel, Thomas ^a   Müller, Lars ^a   Saile, Bernhard ^a   Ramadori, Giuliano ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Extracellular matrix; Fibrogenesis; Fibrosis; Hepatic stellate cells; Interferon gamma; Ito cells; Protease inhibitors; Tumour necrosis factor alpha

Indexed keywords

ACTIVIN; ALPHA ACTIN; BROXURIDINE; COLLAGEN TYPE 3; COMPLEMENT COMPONENT C1S INHIBITOR; FIBRONECTIN; GAMMA INTERFERON; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE INHIBITOR; RNA; SCLEROPROTEIN; TENASCIN; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRITIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMMUNOBLOTTING; IMMUNOPRECIPITATION; ITO CELL; LIVER FIBROSIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; TISSUE REPAIR;

EID: 0343580434     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80151-1     Document Type: Article

References (89)

1. Knittel T, Ramadori G. Current concepts of liver fibrosis. FORUM Trends in Exp Clin Med. 4:1994;236-257.
2. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 328:1993;1828-1835.
3. Gressner AM, Bachem MG. Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases: liver fibrosis as a paradigm. Ann Biol Clin Paris. 52:1994;205-226.
4. Pinzani M. Novel insights into the biology and physiology of the Ito cell. Pharmacol Ther. 66:1995;387-412.
5. Arthur M. Matrix degradation in the liver. Surrenti C, Milani S, Casini A, Pinzani M. Fat-Storing Cells and Liver Fibrosis. 1993;110-127 Kluwer Academic Publishers, Dordrecht/Boston/London.
6. Casini A, Pinzani M, Milani S, Grappone C, Galli G, Jezequel AM, et al. Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. Gastroenterology. 105:1993;245-253.
7. Knittel T, Janneck T, Müller L, Fellmer P, Ramadori G. Transforming growth factor-β1 regulated gene expression of Ito cells. Hepatology. 24:1996;352-360.
8. Iredale JP, Goddard S, Murphy G, Benyon RC, Arthur M. Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci. 89:1995;75-81.
9. Pinzani M, Gentilini A, Caligiuri A, De Franco R, Pellegrini G, Milani S, et al. Transforming growth factor-beta 1 regulates platelet-derived growth factor receptor beta subunit in human liver fat-storing cells. Hepatology. 21:1995;232-239.
10. Van Ostade X, Tavernier J, Fiers W. Structure-activity studies of human tumour necrosis factors. Protein Eng. 7:1994;5-22.
11. Tracey K, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 45:1994;491-503.
12. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 10:1992;411-452.
13. Marinos G, Naoumov NV, Rossol S, Torre F, Wong PY, Gallati H, et al. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology. 108:1995;1453-1463.
14. Diez RA, Tilz GP, Gutierrez GF, Gil EB, Murr C, Wachter H, et al. Neopterin and soluble tumor necrosis factor receptor type I in alcohol-induced cirrhosis. Hepatology. 21:1995;976-978.
15. Larrea E, Garcia N, Qian C, Civeira MP, Prieto J. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology. 23:1996;210-217.
16. Paramo JA, Sangro B, Prosper F, Quiroga J, Rifon J, Rocha E. Increased concentrations of tumor necrosis factor and interleukin-6 contribute to the hemostatic abnormalities in advanced liver disease. Haemostasis. 23:1995;305-311.
17. Rodriguez RE, Gonzalez RE, Santolaria FF, Milena AA, Rodriguez MF, Oramas RJ, et al. Cytokine levels in acute alcoholic hepatitis: a sequential study. Drug Alcohol Depend. 39:1995;23-27.
18. Chamulitrat W, Blazka ME, Jordan SJ, Luster MI, Mason RP. Tumor necrosis factor-alpha and nitric oxide production in endotoxin-primed rats administered carbon tetrachloride. Life Sci. 57:1995;2273-2280.
19. Nanji AA, Griniuviene B, Yacoub LK, Fogt F, Tahan SR. Intercellular adhesion molecule-1 expression in experimental alcoholic liver disease: relationship to endotoxemia and TNF alpha messenger RNA. Exp Mol Pathol. 62:1995;42-51.
20. Hoffmann R, Grewe M, Estler HC, Schulze SA, Decker K. Regulation of tumor necrosis factor-alpha-mRNA synthesis and distribution of tumor necrosis factor-alpha-mRNA synthesizing cells in rat liver during experimental endotoxemia. J Hepatol. 20:1994;122-128.
21. Löhr HF, Schlaak JF, Gerken G, Fleischer B, Dienes HP, Meyer zum Büschenfelde K-H. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocyte from patients with chronic hepatitis of different etiology. Liver. 14:1994;161-166.
22. Hussain MJ, Mustafa A, Gallati H, Mowat AP, Mieli VG, Vergani D. Cellular expression of tumour necrosis factor-alpha and interferon-gamma in the liver biopsies of children with chronic liver disease. J Hepatol. 21:1994;816-821.
23. Gonzalez AR, García MC, García BL, Moreno OR, Alonso JL, Yague E, et al. Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med. 179:1994;841-848.
24. Kamimura S, Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology. 22:1995;1304-1309.
25. Grewe M, Gausling R, Gyufko K, Hoffmann R, Decker K. Regulation of the mRNA expression for tumor necrosis factor-alpha in rat liver macrophages. J Hepatol. 20:1994;811-818.
26. Gressner AM, Althaus M. Effects of murine recombinant interferon-gamma on rat liver fat storing cell proliferation, cluster formation and proteoglycan synthesis. Biochem Pharmacol. 40:1990;1953-1962.
27. Ramadori G, Knittel T, Odenthal M, Schwogler S, Neubauer K, Meyer zum Büschenfelde K-H. Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines. Gastroenterology. 103:1992;1313-1321.
28. Schwögler S, Odenthal M, Knittel T, Meyer zum Büschenfelde K-H. Fat-storing cells of the rat liver synthesize and secrete Cl-esterase inhibitor; modulation by cytokines. Hepatology. 16:1992;794-802.
29. Rockey DC, Maher JJ, Jarnagin WR, Gabbiani G, Friedman SL. Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma. Hepatology. 16:1992;776-784.
30. Helyar L, Bundschuh DS, Laskin JD, Laskin DL. Induction of hepatic Ito cell nitric oxide production after acute endotoxemia. Hepatology. 20:1994;1509-1515.
31. Mallat A, Preaux AM, Blazejewski S, Rosenbaum J, Dhumeaux D, Mavier P. Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology. 21:1995;1003-1010.
32. Marra F, Valente AJ, Pinzani M, Abboud HE. Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest. 92:1993;1674-1680.
33. Rockey DC, Chung JJ. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility. J Clin Invest. 95:1995;1199-1206.
34. Carlin B, Jaffe R, Bender B, Chung A. Entactin, a novel basal lamina-associated sulfated glycoprotein. J Biol Chem. 1981;5209-5214.
35. Dijkstra CD, Döpp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology. 54:1985;589-599.
36. Kornblihtt A, Vibe Pedersen K, Baralle F. Human fibronectin: molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain. EMBO J. 3:1984;221-226.
37. Weller A, Beck S, Ekblom P. Amino acid sequence of mouse tenasoin and differential expression of two renascin isoforms during embryogenesis. J Cell Biol. 112:1991;355-362.
38. Durkin M, Chakravarti S, Bartos B, Liu S, Friedman R, Chung A. Amino acid sequence and domain structure of entactin. Homology with epidermal growth factor precursor and low density lipoprotein receptor. J Cell Biol. 107:1988;2749-2756.
39. Brinker J, Gudas L, Loidl H, Wang S, Rosenbloom J, Kefalides N, et al. Restricted homology between human alpha 1 type IV and other procollagen chains. Proc. Natl Acad Sci USA. 82:1985;3649-3653.
40. Loidl H, Brinke RJ, May M, Pihlajaniemi T, Morrow S, Rosenbloom J, et al. Molecular cloning and carboxyl-propeptide analysis of human type III procollagen. Nucleic Acids Res. 12:1984;9383-9394.
41. Gehring M, Shiels B, Northemann W, de Bruijn M, Kan C, Chain A, et al. Sequence of rat liver alpha 2-macroglobulin and acute phase control of its messenger RNA. J Biol Chem. 262:1987;446-454.
42. Tosi M, Duponchel C, Bourgarel P, Colomb M, Meo T. Molecular cloning of human Cl inhibitor; sequence homologies with alpha 1-antitrypsin and other members of the serpins superfamily. Gene. 265:1986;265-272.
43. Zeheb R, Gelehrter T. Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene. 73:1988;459-468.
44. Schwartz RJ, Haron JA, Rothblum KM, Dugaiczyk A. Regulation of muscle differentiation: cloning of sequences from alpha-actin messenger ribonucleic acid. Biochemistry. 19:1980;5883-5890.
45. Knittel T, Aurisch S, Neubauer K, Eichhorst S, Ramadori G. Cell type specific expression of neural cell adhesion molecule (N-CAM) in Ito cell sof rat liver: up-regulation during in vitro activation and in hepatic tissue repair. Am J Pathol. 149:1996;449-462.
46. Himmler A, Maurer-Fogy I, Kronke M, Scheurich P, Pfizenmaier K, Lantz M, et al. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein. DNA Cell Biol. 9:1990;705-715.
47. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GH, et al. Cloning and expression of cDNAs for two distinct murine necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA. 88:1991;2830-2834.
48. Devereux J, Hacberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:1984;387-395.
49. Fort P, Marty L, Piechaczyk M, Sabrouty SE, Dani C, Jeanicur P, et al. Various adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1985;1431-1442.
50. Barbu V, Dautry F. Northern blot normalization with a 28S rRNA oligonucleotide probe. Nucleic Acids Res. 17:1989;7115.
51. Neubauer K, Knittel T, Aurisch S, Fellmer P, Ramadori G. Glial fibrillary acidic protein - a cell type specific marker protein for Ito cells in vivo and in vitro. J Hepatol. 24:1996;719-730.
52. Knittel T, Fellmer P, Ramadori G. Gene expression and regulation of plasminogen activator inhibitor type I in hepatic stellate cells of rat liver. Gastroenterology. 111:1996;745-754.
53. Knittel T, Armbrust T, Neubauer K, Ramadori G. Expression of von Willebrand factor in normal and diseased rat livers and in cultivated liver cells. Hepatology. 21:1995;470-476.
54. Knittel T, Odenthal M, Schuppan D, Schwögler S, Just M, Meyer zum Büschenfelde K-H, et al. Synthesis of undulin by rat liver fat storing cells: comparison with fibronectin and tenascin. Exp Cell Res. 203:1992;312-320.
55. Knittel T, Schuppan D, Meyer zum Büschenfelde K-H, Ramadori G. Differential expression of collagen types I, III, and IV by fat-storing (Ito) cells in vitro. Gastroenterology. 102:1992;1724-1735.
56. Knittel T, Armbrust T, Schwögler S, Schuppan D, Meyer zum Büschenfelde K-H, Ramadori G. Distribution and cellular origin of undulin in the rat liver. Lab Invest. 67:1992;779-787.
57. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-682.
58. Towbin H, Stachelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 26:1979;4350-4354.
59. Schwögler S, Neubauer K, Knittel T, Ramadori G. Entactin gene expression in diseased rat livers and in cultivated liver cells. Lab Invest. 4:1994;525-536.
60. Andus T, Ramadori G, Heinrich PC, Knittel T, Mayer zum Büschenfelde K-H. Cultured Ito cells of rat liver express the α2-macroglobulin gene. Eur J Biochem. 168:1987;641-646.
61. Pinzani M, Knauss TC, Pierce GF, Hsieh P, Kenney W, Dubyak GR, Abboud HE. Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells. Am J Physiol. 260:1991;C485-C491.
62. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest. 84:1989;1786-1793.
63. Beno DW, Mullen J, Davis BH. Lipoxygenase inhibitors block PDGF-induced mitogenesis: a MAPK-independent mechanism that blocks fos and egr. Am J Physiol. 268:1995;C604-C610.
64. Bachem MG, Meyer D, Schafer W, Riess U, Melchior R, Sell KM, et al. The response of rat liver perisinusoidal lipocytes to polypeptide growth regulator changes with their transdifferentiation into myofibroblast-like cells in culture. J Hepatol. 18:1993;40-52.
65. Failli P, Ruocco C, De FR, Caligiuri A, Gentilini A, Giotti A, et al. The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx. Am J Physiol. 269:1995;C1133-C1139.
66. Friedman SL, Yamasaki G, Wong L. Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in in vivo. J Biol Chem. 269:1994;10551-10558.
67. Yelavarthi K, Hunt J. Analysis of p60 and p80 tumor necrosis factor-alpha receptor messenger RNA and protein in human placentas. Am J Pathol. 143:1993;1131-1141.
68. Brennan F, Gibbons D, Mitchell T, Cope A, Maini R, Feldmann M. Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints. Eur J Immunol. 22:1992;1907-1912.
69. Torre-Amione G, Kapadia S, Lee J, Durand J, Bies R, Young J, et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 93:1995;704-711.
70. Totpal K, Chaturvedi M, LaPushin R, Aggarwal B. Retinolds downregulate both p60 and p80 forms of tumor necrosis factor receptors in human histiocytic lymphoma U-937 cells. Blood. 85:1995;3547-3555.
71. Czaja MJ, Xu J, Alt E. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology. 108:1995;1849-1854.
72. Engers R, van Roy F, Heymer T, Ramp U, Moll R, Dienst M, et al. Growth inhibition in clonal subpopulations of a human epithelioid sarcoma cell line by retinoic acid and tumour necrosis factor alpha. Br J Cancer. 73:1996;491-498.
73. van Valen F, Winkelmann W, Burdach S, Gobel U, Jurgens H. Interferon gamma and tumour necrosis factor alpha induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro. J Cancer Res Clin. 119:1993;615-621.
74. Benador NM, Grau GE, Ruef C, Girardin EP. Endogenous TNF-αalpha modulates the proliferation of rat mesangial cells and their prostaglandin E2 synthesis. Microvasc Res. 50:1995;154-161.
75. Zhang Y, Harada A, Bluethmann H, Wang JB, Nakao S, Mukaida N, et al. Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hacmatopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro. Blood. 2930-2937:1995.
76. Hori M, Kamijo R, Takeda K, Nagumo M. Downregulation of c-myc expression by tumor necrosis factor-alpha in combination with transforming growth factor-beta or interferon-gamma with concomitant inhibition of proliferation in human cell lines. J Interferon Res. 14:1994;49-55.
77. Kawakami M, Watanabe N, Ogawa H, Kato A, Sando H, Yamada N, et al. Cachectin/TNF kills or inhibits the differentiation of 3T3-L1 cells according to developmental stage. J Cell Physiol. 138:1989;1-7.
78. Stephens JM, Butts MD, Pekala PH. Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha. J Mol Endocrinol. 9:1992;61-72.
79. Torti FM, Torti SV, Larrich JW, Ringold GM. Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta. J Cell Biol. 108:1989;1105-1113.
80. Ninomiya TJ, Torti FM, Ringold GM. Tumor necrosis factor-induced c-myc expression in the absence of mitogenesis is associated with inhibition of adipocyte diffentiation. Proc Natl Acad Sci USA. 90:1993;9611-9615.
81. Bachem MG, Sell KM, Melchior R, Kropf J, Eller T, Gressner AM. Tumor necrosis factor alpha (TNF alpha) and transforming growth factor beta 1 (TGF beta 1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts. Virchows Arch B. 63:1993;123-130.
82. Bemelmans M, van Tits L, Buurman W. Tumor necrosis factor: function, release and clearance. Crit Rev Immunol. 16:1996;1-11.
83. Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55 kDA TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol. 154:1995;1307-1316.
84. Neumann B, Machleidt T, Lifka A, Pfeffer K, Vestweber D, Mak T, et al. Criticial role of 55-kilodalton TNF receptor in TNF induced adhesion molecule expression and leukocyte organ infiltration. J Immunol. 156:1996;1587-1593.
85. Zhang F, zur Hausen A, Hoffmann R, Grewe M, Decker K. Rat liver macrophages express the 66 kDa tumor necrosis factor receptor: modulation by interferon-gamma, lipopolysaccharide and tumor necrosis factor-alpha. Biol Chem Hoppe Seyler. 375:1994;249-254.
86. Armendariz BJ, Katayama K, Seyer JM. Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin-1 beta, tumor necrosis factor alpha, and transforming growth factor beta in Ito cells. J Biol Chem. 267:1992;14316-14321.
87. Matsuoka M, Pham NT, Tsukamoto H. Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver. 9:1989;71-78.
88. Weiner FR, Giambrone MA, Czaja MJ, Shah A, Annoni G, Takahashi S, et al. Ito-cell gene expression and collagen regulation. Hepatology. 11:1990;111-117.
89. Greenwel P, Iraburu M, Reyes R, Meraz C, Casado E, Solis H, et al. Induction of an acute phase response in rats stimulates the expression of alpha 1(I) procollagen messenger ribonucleic acid in their livers. Possible role of interleukin-6. Lab Invest. 72:1995;83-91.